APA (7th ed.) Citation

Breitkreutz, I., Goldschmidt, H., Raab, M., Heiß, C., Perne, A. M., Beimler, J., . . . Zeier, M. (2014). Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure. Bone marrow transplantation, 49(11), . https://doi.org/10.1038/bmt.2014.165

Chicago Style (17th ed.) Citation

Breitkreutz, Iris, et al. "Bortezomib Improves Outcome After SCT in Multiple Myeloma Patients with End-stage Renal Failure." Bone Marrow Transplantation 49, no. 11 (2014). https://doi.org/10.1038/bmt.2014.165.

MLA (9th ed.) Citation

Breitkreutz, Iris, et al. "Bortezomib Improves Outcome After SCT in Multiple Myeloma Patients with End-stage Renal Failure." Bone Marrow Transplantation, vol. 49, no. 11, 2014, https://doi.org/10.1038/bmt.2014.165.